Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Scientists uncover how the innate immune system detects and fights HIV-1

Human immunodeficiency virus 1, more commonly known as HIV-1, is known for its uncanny ability to evade the immune system.

8 Jul 2022

New non-invasive treatment for patients suffering from treatment-resistant depression and dementia

A joint research team from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and City University of Hong Kong (CityU) has discovered that the electrical stimulation of the eye surface can alleviate depression-like symptoms and improve cognitive function in animal models.

8 Jul 2022

Fatty foods may expand waistline and cause havoc to the brain

New research shows that fatty foods may not only be adding to your waistline but also playing havoc with your brain.

8 Jul 2022

COVID-19 was the third leading cause of death in the US in 2020 and 2021

In a recent article published in the journal JAMA Internal Medicine, investigators examined the major causes of mortality across the United States (US) in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

7 Jul 2022

Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer's disease symptoms

There is "good evidence" that drugs to treat attention deficit hyperactivity disorder (ADHD) might also successfully treat key aspects of Alzheimer's disease, finds a pooled data analysis of the available research, published online in the Journal of Neurology Neurosurgery & Psychiatry.

6 Jul 2022

COVID-19 was third leading cause of death in the United States between March 2020 and October 2021

COVID-19 was the third leading cause of death in the United States between March 2020 and October 2021, according to an analysis of national death certificate data by researchers at the National Cancer Institute, part of the National Institutes of Health. The study appears July 5 in JAMA Internal Medicine.

5 Jul 2022

Scientists offer a set of recommendations to improve future research on diet and dementia

Anyone searching the internet for brain-healthy foods will find no shortage of stories making dietary recommendations. Some of those stories point to observational studies that have suggested a link between the lower or greater intake of certain foods and the risk of dementia.

5 Jul 2022

Influenza vaccination may provide protective effect against Alzheimer’s disease

Researchers compared Alzheimer's Disease development risks among recipients and non-recipients of intramuscularly administered influenza vaccines.

5 Jul 2022

Elevated cerebrospinal fluid biomarkers of neuroinflammation in NeuroCOVID patients

A new research paper studied several biomarkers associated with neuronal injury, neuroinflammation, and neurodegeneration in NeuroCOVID adults who experienced a CNS syndrome during acute SARS-CoV-2 infection.

4 Jul 2022

Scientists prove the “neuroprotective” function of p62 protein in a mouse model

Neurodegenerative diseases like Alzheimer’s and Parkinson’s are defined by pathogenic accumulation of toxic proteins in the brain.

1 Jul 2022

Optical fiber holds promise for use in deep-tissue studies of patients’ brains with Alzheimer’s disease

An optical fiber as thin as a strand of hair holds promise for use in minimally invasive deep-tissue studies of patients' brains that show the effects Alzheimer's disease and other brain disorders.

30 Jun 2022

Study uncovers new gene that increases Alzheimer's disease risk in women

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S. Scientists have discovered some genetic variants that increase the risk for developing Alzheimer's; the most well-known of these for people over the age of 65 is the APOE ε4 allele.

30 Jun 2022

Study of condensates offers new hope for the treatment of neurodegenerative diseases

The Körber European Science Prize 2022, endowed with one million euros, is to be awarded to the British cell biologist Anthony Hyman.

30 Jun 2022

Study finds more of white matter hyperintensities in postmenopausal women

Women who have gone through menopause may have more of a brain biomarker called white matter hyperintensities than premenopausal women or men of the same age, according to a new study published in the June 29, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Jun 2022

Brain MRIs and genetics may be used to predict the chances of developing Alzheimer's disease

Simon Fraser University researchers are studying how a combination of genetics and brain MRIs may be used to predict the chances of developing Alzheimer's disease in the future.

29 Jun 2022

New machine learning method may improve the identification of genes that cause diseases

A new machine learning method to model gene expression levels might improve the identification of genes that cause human diseases, according to a new study by Penn State College of Medicine researchers.

28 Jun 2022

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

28 Jun 2022

Antiretroviral drug used to treat HIV ameliorates cognitive deficits in mouse model of Down syndrome

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for Genomic Regulation (CRG) and the IrsiCaixa AIDS Research Institute, a center jointly promoted by the "la Caixa" Foundation and the Department of Health of the Generalitat de Catalunya.

28 Jun 2022

Study elucidates the molecular mechanisms of acetylcholine for learning and memory

Acetylcholine (ACh) is a neuromodulator with a central role in aversive learning - rapid conditioning to unpleasant smell, taste, or touch.

28 Jun 2022

APOEε4 may confer increased risk for CTE-related neuropathological outcomes among older adults with repetitive head impacts

How could two individuals who both played football for 10 years and developed CTE have different disease severity? How could some individuals develop dementia in their 50's while other never develop dementia at all? Perhaps the answer lies in their genes.

27 Jun 2022

Alzheimer's Disease News and Research

Further Reading

Scientists uncover how the innate immune system detects and fights HIV-1

New non-invasive treatment for patients suffering from treatment-resistant depression and dementia

Fatty foods may expand waistline and cause havoc to the brain

COVID-19 was the third leading cause of death in the US in 2020 and 2021

Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer's disease symptoms

COVID-19 was third leading cause of death in the United States between March 2020 and October 2021

Scientists offer a set of recommendations to improve future research on diet and dementia

Influenza vaccination may provide protective effect against Alzheimer’s disease

Elevated cerebrospinal fluid biomarkers of neuroinflammation in NeuroCOVID patients

Scientists prove the “neuroprotective” function of p62 protein in a mouse model

Optical fiber holds promise for use in deep-tissue studies of patients’ brains with Alzheimer’s disease

Study uncovers new gene that increases Alzheimer's disease risk in women

Study of condensates offers new hope for the treatment of neurodegenerative diseases

Study finds more of white matter hyperintensities in postmenopausal women

Brain MRIs and genetics may be used to predict the chances of developing Alzheimer's disease

New machine learning method may improve the identification of genes that cause diseases

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

Antiretroviral drug used to treat HIV ameliorates cognitive deficits in mouse model of Down syndrome

Study elucidates the molecular mechanisms of acetylcholine for learning and memory

APOEε4 may confer increased risk for CTE-related neuropathological outcomes among older adults with repetitive head impacts

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News